226 EFFICACY AND SAFETY OF SORAFENIB AT LONG TERM IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): NEED TO SCREEN FOR CARDIOVASCULAR EVENTS AFTER LONG TERM ADMINISTRATION | Publicación